Pyrotinib Uses, Dosage, Side Effects and more

Pyrotinib is under investigation in clinical trial NCT03756064 (Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer).

Trade Name Pyrotinib
Generic Pyrotinib
Type
Formula C32H31ClN6O3
Weight Average: 583.09
Monoisotopic: 582.2146166
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share